← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Remd Biotherapeutics, Inc.
Camarillo, CA
$4,634,606
Total funding
2
Grants
Funding over time
peak $993.8K · FY2016–21$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$4,634,606 · 2
By mechanism
R44$2,980,940 · 1
R42$1,653,666 · 1
Investigators at Remd Biotherapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Assessment of Multiple Dose Administration ofGlucagon Receptor Blocker REMD477 in Type 1 Diabetes$993,807
R44 · FY2021 · DK
Assessment of Multiple Dose Administration ofGlucagon Receptor Blocker REMD477 in Type 1 Diabetes$993,807
R44 · FY2020 · DK
Assessment of Multiple Dose Administration of Glucagon Receptor Blocker REMD477 in Type 1 Diabetes$993,326
R44 · FY2019 · DK
Assessment of the glucagon receptor blocker REMD-477 on insulin requirements in type 1 diabetes$748,101
R42 · FY2017 · DK
Assessment of the glucagon receptor blocker REMD-477 on insulin requirements in type 1 diabetes$680,901
R42 · FY2018 · DK
Assessment of the glucagon receptor blocker REMD-477 on insulin requirements in type 1 diabetes$224,664
R42 · FY2016 · DK